Analysis of Combined Transcriptomes Identifies Gene Modules that Differentially Respond to Pathogenic Stimulation of Vascular Smooth Muscle and Endothelial Cells

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Pan, Xiaokang ^a,b   Wang, Bowen ^c   Yuan, Tiezheng ^a   Zhang, Mengxue ^a,d   Kent, K Craig ^c   Guo, Lian Wang ^a,d  

^a University of Wisconsin Health   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ANTIBODY SPECIFICITY; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; PROCEDURES; SEQUENCE ANALYSIS; SMOOTH MUSCLE CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

CELL LINE; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; SEQUENCE ANALYSIS, RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85040449506     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-18675-2     Document Type: Article

References (61)

1. Mozaffarian, D. et al. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 133, 447-454 (2016).
2. Thukkani, A. K. et al. Endovascular intervention for peripheral artery disease. Circulation research 116, 1599-613 (2015).
3. Byrne, R. A. et al. Stent thrombosis and restenosis: what have we learned and where are we going The Andreas Grüntzig Lecture ESC 2014. European heart journal 36, 3320-31 (2015).
4. Asahara, T. et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91, 2793-801 (1995).
5. Fitzgerald, T. N. et al. Laminar shear stress stimulates vascular smooth muscle cell apoptosis via the Akt pathway. Journal of cellular physiology 216, 389-95 (2008).
6. Serruys, P. W. et al. Rapamycin eluting stent: The onset of a new era in interventional cardiology. Heart 87, 305-307 (2002).
7. Gershlick, A. et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation 109, 487-93 (2004).
8. Stone, G. W. et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. New England Journal of Medicine 375, 2223-35 (2016).
9. Banerjee, S. et al. The resolute™ integrity zotarolimus-eluting stent in coronary artery disease: A review. Cardiology and therapy 2, 17-25 (2013).
10. Pendyala, L. K. et al. The first-generation drug-eluting stents and coronary endothelial dysfunction. JACC: Cardiovascular Interventions 2, 1169-77 (2009).
11. Chen, C. et al. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. Journal of Surgical Research 88, 26-33 (2000).
12. Kawasawa, Y. I. et al. RNA-seq analysis of developing olfactory bulb projection neurons. Molecular and Cellular Neuroscience 74, 78-86 (2016).
13. Langmead, B. et al. Fast gapped-read alignment with Bowtie 2. Nature Methods 9, 357-359 (2012).
14. Kim, D. et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome biology 14, R36 (2013).
15. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology 28, 511-5 (2010).
16. de Hoon, M. J. et al. Open source clustering software. Bioinformatics 20, 1453-4 (2004).
17. Saldanha, A. T. Java Treeview-extensible visualization of microarray data. Bioinformatics 20, 3246-3248 (2004).
18. Huang, D. W. et al. The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome biology 8, R183 (2007).
19. Yu, H. et al. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS computational biology 3, e59 (2007).
20. Rectenwald, J. E. et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102, 1697-702 (2000).
21. Bradley, J. R. TNFmediated inflammatory disease. The Journal of pathology 214, 149-60 (2008).
22. Franscini, N. et al. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C. Circulation 110, 2903-9 (2004).
23. Girvan, M. et al. Community structure in social and biological networks. Proceedings of the national academy of sciences 99, 7821-6 (2002).
24. Peppel, K. et al. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovascular research 65, 674-82 (2005).
25. Eun, S. Y. et al. IL-1 enhances vascular smooth muscle cell proliferation and migration via P2Y 2 receptor-mediated RAGE expression and HMGB1 release. Vascular pharmacology 72, 108-17 (2015).
26. Madge, L. A. et al. TNF signaling in vascular endothelial cells. Experimental and molecular pathology 70, 317-25 (2001).
27. Makó, V. et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL1, TNF, and LPS. Cytometry Part A 77, 962-70 (2010).
28. Cooley, B. C. et al. TGF-signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Science translational medicine 227, ra34 (2014).
29. Rastogi, S. et al. TNF-response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase andp73. Cell Death & Differentiation 19, 274-83 (2012).
30. Bean, D. M. et al. esyN: network building, sharing and publishing. PloS one 9, e106035 (2014).
31. Smith, R. N. et al. InterMine: A flexible data warehouse system for the integration and analysis of heterogeneous biological data. Bioinformatics 28, 3163-5 (2012).
32. MacLellan, W. R. et al. Systems-based approaches to cardiovascular disease. Nature Reviews Cardiology 9, 172-84 (2012).
33. Bar-Joseph, Z. et al. Computational discovery of gene modules and regulatory networks. Nature biotechnology 21, 1337-42 (2003).
34. Alexander, M. R. et al. Interleukin-1 modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGFDD via NF-B-dependent mechanisms. Physiological genomics 44, 417-29 (2012).
35. Khachigian, L. M. et al. c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury Inhibition by a novel DNA enzyme targeting c-Jun. Journal of Biological Chemistry 277, 22985-91 (2002).
36. Suzuki, T. et al. Krüppel-like factor 5 shows proliferation-specific roles in vascular remodeling, direct stimulation of cell growth, and inhibition of apoptosis. Journal of Biological Chemistry 284, 9549-57 (2009).
37. Shimoda, L. A. 55th Bowditch Lecture: Effects of chronic hypoxia on the pulmonary circulation: role of HIF-1. Journal of Applied Physiology 113, 1343-52 (2012).
38. Yue, T. L. et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circulation Research 75, 1-7 (1994).
39. Xing, D. et al. Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury. Circulation 125, 1533-41 (2012).
40. Wang, N. et al. c-Jun triggers apoptosis in human vascular endothelial cells. Circulation research 85, 387-93 (1999).
41. Kumekawa, M. et al. Inhibition of Monocyte Chemoattractant Protein-1 by Krueppel-Like Factor 5 Small Interfering RNA in the Tumor Necrosis Factor-. ALPHA.-Activated Human Umbilical Vein Endothelial Cells. Biological and Pharmaceutical Bulletin 31, 1609-13 (2008).
42. Zhu, Y. et al. Restenosis Inhibition and Re-differentiation of TGF/Smad3-activated Smooth Muscle Cells by Resveratrol. Scientific Reports 7, 41916 (2017).
43. Ginnan, R. et al. Vascular smooth muscle motility is mediated by a physical and functional interaction of CaM kinase II-2 and Fyn. Journal of Biological Chemistry 3, jbc-M113 (2013).
44. Dumler, I. et al. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. Journal of Biological Chemistry 273, 315-21 (1998).
45. Kirabo, A. et al. Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice. Journal of molecular and cellular cardiology 50, 1026-34 (2011).
46. Li, G. et al. Identification of PI3K regulatory subunit p55 as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation. Cardiovascular research 105, 75-85 (2015).
47. Amano, M. et al. Identification of Tau and MAP2 as novel substrates of Rhokinase and myosin phosphatase. Journal of neurochemistry 87, 780-90 (2003).
48. Hocevar, B. A. et al. Disabled-2 (Dab2) mediates transforming growth factor (TGF)-stimulated fibronectin synthesis through TGF-activated kinase 1 and activation of the JNK pathway. Journal of Biological Chemistry 280, 25920-7 (2005).
49. Kondo, A. et al. A new paxillin-binding protein, PAG3/Pap/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration. Molecular biology of the cell 11, 1315-27 (2000).
50. Aoudjit, F. et al. P21Waf1/Cip1 in endothelial cell survival. Cardiovascular research 61, 648-50 (2004).
51. Hogan, N. T. et al. Transcriptional networks specifying homeostatic and inflammatory programs of gene expression in human aortic endothelial cells. eLife 6 (2017).
52. Missiou, A. et al. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121, 2033-44 (2010).
53. Kolyada, A. Y. et al. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells. Molecular medicine 7, 329 (2001).
54. Zhang, H. et al. A new functional domain of Bcl6 family that recruits histone deacetylases. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1540, 188-200 (2001).
55. Guo, L. et al. Tribbles homolog 3 is induced by high glucose and associated with apoptosis in human endothelial cells. Molecular medicine reports 12, 1963-70 (2015).
56. Cadwell, C. M. et al. Ankyrin-G inhibits endocytosis of cadherin dimers. Journal of Biological Chemistry 291, 691-704 (2016).
57. Cheng, C. et al. Ets2 determines the inflammatory state of endothelial cells in advanced atherosclerotic lesions. Circulation research 109, 382-95 (2011).
58. Zhang, G. et al. N-myc downstream regulated gene-1 promotes vascular inflammation through activating both NF-kappaB and c-Jun/AP-1 pathways in endothelial cells. The FASEB Journal 30, 957-10 (2016).
59. Lapalombella, R. et al. Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood 120, 4621-34 (2012).
60. Torres, R. A. et al. Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation. Arteriosclerosis, thrombosis, and vascular biology 31, 2424-31 (2011).
61. Chan, S. S. et al. What is a master regulator Journal of stem cell research & therapy 3 (2013).